Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review

Published:2021-09-06 Issue:11 Volume:37 Page:1855-1858
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Becker Guillaume¹²^ORCID,Rougerie Fabien³,Sabo Amelia-Naomi²,Dalmas Marie-Caroline⁴,Ayme-Dietrich Estelle¹²^ORCID,Monassier Laurent¹²^ORCID

Affiliation:

1. Pôle pharmacie-pharmacologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

2. Laboratoire de Pharmacologie et Toxicologie NeuroCardiovasculaire UR7296, Département Universitaire de Pharmacologie, Addictologie, Toxicologie et Thérapeutique, Université de Strasbourg, Strasbourg, France

3. Département de Médecine Générale, Faculté de Médecine, Université de Strasbourg, Strasbourg, France

4. Service de Médecine Interne, Endocrinologie & Nutrition, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1971183

Reference24 articles.

1. Current pharmacotherapy of bradykinin-mediated angioedema

2. Angioedema

3. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE

4. Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefit and risk evaluation of quinapril hydrochloride;Expert Opinion on Drug Safety;2023-04-03

2. Ramipril;Reactions Weekly;2021-10